{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T21:06:13Z","timestamp":1776027973207,"version":"3.50.1"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T00:00:00Z","timestamp":1415059200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1001752","type":"journal-article","created":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T18:54:48Z","timestamp":1415127288000},"page":"e1001752","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Sublingual Misoprostol versus Intramuscular Oxytocin for Prevention of Postpartum Hemorrhage in Uganda: A Double-Blind Randomized Non-Inferiority Trial"],"prefix":"10.1371","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct01866241","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Esther C.","family":"Atukunda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Siedner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celestino","family":"Obua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Godfrey R.","family":"Mugyenyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Twagirumukiza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amon G.","family":"Agaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,11,4]]},"reference":[{"key":"ref1","unstructured":"World Health Organization, United Nations Children's Fund, United Nations Population Fund, World Bank (2012) Trends in maternal mortality: 1990\u20132010. WHO, UNICEF, UNFPA and The World Bank estimates. Geneva: World Health Organization."},{"key":"ref2","unstructured":"United Nations Department of Economic and Social Affairs Population Division (2013) World population prospects: the 2012 revision. New York: United Nations Department of Economic and Social Affairs Population Division."},{"key":"ref3","unstructured":"Uganda Ministry of Health (2010) Clinical guidelines for prevention and treatment of post partum haemorrhage using misoprostol. Kampala: Uganda Ministry of Health."},{"key":"ref4","unstructured":"World Health Organization (2012) WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva: World Health Organization."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2147\/IJWH.S51661","article-title":"Prevention of postpartum hemorrhage in low-resource settings: current perspectives","volume":"5","author":"N Prata","year":"2013","journal-title":"Int J Womens Health"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0140-6736(13)62171-6","article-title":"Registration, procurement, distribution, and use of misoprostol in Uganda: an interview-based observational study","volume":"382","author":"EC Atukunda","year":"2013","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e1001524","DOI":"10.1371\/journal.pmed.1001524","article-title":"Effect on postpartum hemorrhage of prophylactic oxytocin (10 IU) by injection by community health officers in Ghana: a community-based, cluster-randomized trial","volume":"10","author":"CK Stanton","year":"2013","journal-title":"PLoS Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1016\/j.ijgo.2007.09.004","article-title":"misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects","volume":"99","author":"OS Tang","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"ref9","unstructured":"Katzung GB (2010) Basic principles of pharmacology. In: Katzung GB, Masters SB, Trevor AJ, editors. Basic and clinical pharmacology, 12th edition. New York: McGraw-Hill Medical."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijgo.2012.09.002","article-title":"Prevention of postpartum hemorrhage with misoprostol","volume":"119","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"key":"ref11","first-page":"CD000494","article-title":"Prostaglandins for preventing postpartum haemorrhage","volume":"8","author":"O Tuncalp","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1258\/jrsm.2012.120044","article-title":"Rethinking WHO guidance: review of evidence for misoprostol use in the prevention of postpartum haemorrhage","volume":"105","author":"CS Chu","year":"2012","journal-title":"J R Soc Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0140-6736(06)69522-6","article-title":"Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial","volume":"368","author":"RJ Derman","year":"2006","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1471-0528.2010.02807.x","article-title":"Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial","volume":"118","author":"N Mobeen","year":"2011","journal-title":"BJOG"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(01)05835-4","article-title":"WHO multicentre randomised trial of misoprostol in the management of the third stage of labour","volume":"358","author":"AM Gulmezoglu","year":"2001","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ijgo.2006.12.016","article-title":"Misoprostol versus oxytocin for the reduction of postpartum blood loss","volume":"97","author":"TF Baskett","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00404-009-1019-y","article-title":"A randomized controlled trial of prophylactic sublingual misoprostol versus intramuscular methyl-ergometrine versus intramuscular 15-methyl PGF2alpha in active management of third stage of labor","volume":"280","author":"A Vaid","year":"2009","journal-title":"Arch Gynecol Obstet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijgo.2005.10.008","article-title":"Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section","volume":"92","author":"N Vimala","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2004.05.016","article-title":"Sublingual misoprostol versus methlergometrine for active management of third stage of labor","volume":"87","author":"N Vimala","year":"2004","journal-title":"Int J Gynaecol Obstet"},{"key":"ref20","unstructured":"Uganda Ministry of Health (2010) Uganda clinical guidelines: national guidelines on management of common conditions. Kampala: Uganda Ministry of Health."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1471-0528.2012.03341.x","article-title":"Prevention of postpartum haemorrhage with sublingual misoprostol or oxytocin: a double-blind randomised controlled trial","volume":"119","author":"MB Bellad","year":"2012","journal-title":"BJOG"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/bmj.331.7519.723","article-title":"Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial","volume":"331","author":"L Hoj","year":"2005","journal-title":"BMJ"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.2012.87802","article-title":"Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement","volume":"308","author":"G Piaggio","year":"2012","journal-title":"JAMA"},{"key":"ref24","first-page":"CD001808","article-title":"Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage","volume":"10","author":"G Westhoff","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1471-0528.1997.tb12020.x","article-title":"Routine oxytocin in the third stage of labour: a placebo controlled randomised trial","volume":"104","author":"L Nordstrom","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7326\/0003-4819-134-8-200104170-00012","article-title":"The revised CONSORT statement for reporting randomized trials: explanation and elaboration","volume":"134","author":"DG Altman","year":"2001","journal-title":"Ann Intern Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00404-013-3026-2","article-title":"Sublingual misoprostol versus intravenous oxytocin in prevention of post-partum hemorrhage","volume":"289","author":"R Tewatia","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijgo.2011.09.016","article-title":"Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women","volume":"116","author":"P Chaudhuri","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"key":"ref29","first-page":"982","article-title":"Commentary on \u201cprevention of postpartum haemorrhage with sublingual misoprostol or oxytocin: a double-blind, randomised controlled trial\u201d","volume":"119","author":"A Weeks","year":"2012","journal-title":"BJOG"},{"key":"ref30","first-page":"650","article-title":"A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor","volume":"83","author":"H Lam","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/AOG.0b013e3182707341","article-title":"Risk of fever after misoprostol for the prevention of postpartum hemorrhage: a meta-analysis","volume":"120","author":"A Elati","year":"2012","journal-title":"Obstet Gynecol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1471-0528.2010.02564.x","article-title":"High fever following postpartum administration of sublingual misoprostol","volume":"117","author":"J Durocher","year":"2010","journal-title":"BJOG"},{"key":"ref33","first-page":"338","article-title":"The misoprostal third stage study: a randomised controlled comparison between orally administered misoprostol and standard management. A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stage labour","volume":"108","author":"F Amant","year":"2001","journal-title":"BJOG"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0002-9378(99)70511-9","article-title":"Perinatal outcome in grand and great-grand multiparity: effects of parity on obstetric risk factors","volume":"181","author":"A Babinszki","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1471-0528.1993.tb12974.x","article-title":"Postpartum haemorrhage in Zimbabwe: a risk factor analysis","volume":"100","author":"VD Tsu","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0028-2243(93)90047-G","article-title":"Risk factors for major obstetric haemorrhage","volume":"48","author":"RW Stones","year":"1993","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["PLoS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1001752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T12:31:33Z","timestamp":1598445093000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1001752"}},"subtitle":[],"editor":[{"given":"Philippa","family":"Middleton","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,11,4]]},"references-count":36,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,11,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1001752","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,4]]}}}